Lê Thi Huong D, Wechsler B, Papo T, Piette J C, Bletry O, Vitoux J M, Kieffer E, Godeau P
Department of Internal Medicine, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
J Rheumatol. 1995 Nov;22(11):2103-13.
To identify the prognostic indicators of patients with Behçet's disease complicated with arterial lesions.
Retrospective chart analysis of 25 consecutive patients with Behçet's disease and angiographically proven arterial lesions.
Occlusive lesions were present in 7 patients, aneurysms in 3, and both occlusive and aneurysmal lesions in 15. High dose corticosteroids were not effective in isolated occlusive lesions and probably contributed to one fatal infection. Death was related to aneurysms in 5 patients. Twenty-seven vascular surgical procedures were performed in 15 patients. Arterial lesions recurred in all patients who did not received postoperative corticosteroids. Within a 2 yr period after operation, the rate of therapy failure was lower in the group of patients treated with a postoperative combination of corticosteroids and immunosuppressive drugs, compared to the group treated with corticosteroids alone. In patients treated for lower limb arterial lesions, the rate of relapse was similar whether venous autologous or prosthetic grafts were used. Graft thrombosis occurred in 3/7 patients given anticoagulants and in 3/4 patients with no antiaggregant or anticoagulant therapy.
Aneurysms have a worse prognosis than occlusive lesions. High dose corticosteroids should not be systematically prescribed for isolated occlusive lesions. Surgery, when feasible, is indicated for aneurysms because they entail a high risk of rupture. Postoperative corticosteroids are necessary to prevent arterial relapse. A combination of corticosteroids and immunosuppressive therapy is more effective than corticosteroids alone. After bypass for lower limb arterial lesions, anticoagulation is warranted to prevent graft thrombosis.
确定白塞病合并动脉病变患者的预后指标。
对25例连续的经血管造影证实有动脉病变的白塞病患者进行回顾性病历分析。
7例患者存在闭塞性病变,3例有动脉瘤,15例既有闭塞性病变又有动脉瘤性病变。大剂量皮质类固醇对孤立的闭塞性病变无效,且可能导致了1例致命感染。5例患者的死亡与动脉瘤有关。15例患者接受了27次血管外科手术。未接受术后皮质类固醇治疗的所有患者动脉病变均复发。术后2年内,与单纯接受皮质类固醇治疗的患者组相比,接受术后皮质类固醇与免疫抑制药物联合治疗的患者组治疗失败率较低。在治疗下肢动脉病变的患者中,使用自体静脉移植物或人工血管移植物时复发率相似。7例接受抗凝治疗的患者中有3例发生移植物血栓形成,4例未接受抗血小板或抗凝治疗的患者中有3例发生移植物血栓形成。
动脉瘤的预后比闭塞性病变更差。对于孤立的闭塞性病变,不应系统性地使用大剂量皮质类固醇。动脉瘤如有破裂的高风险,可行手术治疗。术后使用皮质类固醇对于预防动脉复发是必要的。皮质类固醇与免疫抑制治疗联合使用比单独使用皮质类固醇更有效。下肢动脉病变行搭桥术后,有必要进行抗凝以预防移植物血栓形成。